Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis
Ahmad Y, Demir O, Rajkumar C, Howard JP, Shun-Shin M, Cook C, Petraco R, Jabbour R, Arnold A, Frame A, Sutaria N, Ariff B, Kanaganayagam G, Francis D, Mayet J, Mikhail G, Malik I, Sen S. Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis. Open Heart 2018, 5: e000748. PMID: 29387433, PMCID: PMC5786926, DOI: 10.1136/openhrt-2017-000748.Peer-Reviewed Original ResearchTranscatheter aortic valve implantationDual antiplatelet therapyAortic valve implantationAspirin monotherapyAntiplatelet therapyTAVI centresValve implantationBenefits of DAPTSystematic reviewOptimal antiplatelet strategyIncidence of strokeAntiplatelet useDAPT durationAdverse eventsAntiplatelet strategiesMedian durationInternational guidelinesMonotherapySuitable studiesTherapyElectronic surveyMetaregressionStrokeDeathDuration